UNH Stock Ownership Activity

UNITEDHEALTH GROUP INC 13F holders

15 value investing gurus have made changes to the UNITEDHEALTH GROUP INC (UNH) position according to the gurus' latest SEC quarterly report(s). UNH has been bought (as a new position) by 1 guru(s), the number of UNH shares has been increased by 5, decreased by 9 super investor(s).

Which gurus or hedge funds are buying UNH now?

According to the latest SEC filing(s) UNITEDHEALTH GROUP INC (UNH) has been bought by 6 gurus, out of those top 5 purchases (by % change to portfolio) have been made by Ole Andreas Halvorsen - Viking Global Investors (added shares +263.71%), Eric H. Schoenstein - Jensen Investment Management (added shares +15.38%), Stephen Mandel - Lone Pine Capital (added shares +13.21%), Francois Rochon - Giverny Capital (new buy) and Ronald Muhlenkamp - Muhlenkamp & Co (added shares +0.08%).

To see more about who is investing in UNITEDHEALTH GROUP INC (UNH), please go to the UNH ownership page.

2022 Q4 (14 results)
Ole Andreas Halvorsen
+263.71%
+919,153
+2.45%
3.38%
Eric H. Schoenstein
+15.38%
+185,736
+0.77%
5.78%
Stephen Mandel
+13.21%
+124,144
+0.63%
5.38%
Francois Rochon
buy
+1,733
+0.06%
0.06%
Ronald Muhlenkamp
+0.08%
+19
+0.00%
5.56%
Paul Lountzis
+0.13%
+15
+0.00%
3.33%
David Rolfe
-0.40%
-245
-0.02%
5.90%
Robert Olstein
-10.92%
-950
-0.08%
0.64%
Glenn Greenberg
-51.09%
-1,260
-0.02%
0.02%
Andrew R. Adams
-1.56%
-8,000
-0.10%
6.20%
John Armitage
-7.44%
-85,473
-0.39%
4.85%
David M. Polen
-4.35%
-123,918
-0.19%
4.22%
V. D. Dodge, E. M. Cox
-6.15%
-148,300
-0.09%
1.39%
Ravenel Boykin Curry IV
-24.94%
-726,183
-1.83%
5.49%
Current price: $476.96 9.37% AVG reported price*: $526.26
2022 Q4 (1 result)
Ruane, Cunniff & Goldfarb
-17.06%
-79,350
-1.45%
7.03%
Current price: $476.96 10.04% Reported price*: $530.18
2022 Q3 (13 results)
Ole Andreas Halvorsen
buy
+348,550
+0.82%
0.82%
Stephen Mandel
+17.39%
+139,144
+0.66%
4.47%
Daniel Loeb
+17.54%
+100,000
+0.92%
6.14%
Eric H. Schoenstein
+8.41%
+93,674
+0.41%
5.31%
Ravenel Boykin Curry IV
+1.45%
+41,703
+0.10%
6.70%
Ronald Muhlenkamp
+0.86%
+212
+0.05%
5.58%
Paul Lountzis
-2.33%
-278
-0.10%
3.99%
Robert Olstein
-13.00%
-1,300
-0.11%
0.74%
David Rolfe
-2.59%
-1,619
-0.15%
5.78%
Andrew R. Adams
-4.99%
-27,000
-0.32%
6.14%
David M. Polen
-2.30%
-67,080
-0.09%
4.03%
V. D. Dodge, E. M. Cox
-2.97%
-73,900
-0.05%
1.57%
John Armitage
-23.23%
-347,821
-1.36%
4.51%
Current price: $476.96 5.56% AVG reported price*: $505.04
2022 Q2 (18 results)
Ronald Muhlenkamp
+0.18%
+43
+0.01%
5.90%
Paul Lountzis
-1.46%
-177
-0.06%
4.10%
Robert Olstein
-4.76%
-500
-0.04%
0.77%
David Rolfe
-1.15%
-730
-0.06%
5.54%
Glenn Greenberg
-30.65%
-1,090
-0.02%
0.04%
Francois Rochon
-100.00%
-2,435
-0.08%
0.00%
Robert Torray
-13.63%
-4,121
-0.70%
4.42%
David Tepper
-10.71%
-18,000
-0.58%
4.84%
Ravenel Boykin Curry IV
-1.18%
-34,388
-0.08%
6.41%
Daniel Loeb
-5.79%
-35,000
-0.43%
6.93%
Eric H. Schoenstein
-3.13%
-36,013
-0.15%
4.74%
Andrew R. Adams
-6.88%
-40,000
-0.46%
6.21%
Stephen Mandel
-7.54%
-65,266
-0.32%
3.88%
Ole Andreas Halvorsen
-100.00%
-76,910
-0.18%
0.00%
V. D. Dodge, E. M. Cox
-3.72%
-96,100
-0.06%
1.53%
John Armitage
-8.44%
-138,007
-0.48%
5.19%
Ruane, Cunniff & Goldfarb
-25.40%
-158,384
-2.53%
7.43%
David M. Polen
-22.49%
-846,099
-1.15%
3.96%
Current price: $476.96 7.14% AVG reported price*: $513.63
46 of 380

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.